| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX2 SOX3 TCF4 ZNF628 ESRRB GATA4 ZNF784 YY1 MEF2C JUN JUNB JUND ONECUT3 DMRT1 PBX2 PBX3 MAF | 2.88e-08 | 560 | 117 | 17 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX2 SOX3 TCF4 ZNF628 ESRRB GATA4 ZNF784 YY1 MEF2C JUN JUNB JUND ONECUT3 DMRT1 PBX2 PBX3 MAF | 3.36e-08 | 566 | 117 | 17 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX2 SOX3 TCF4 ZNF628 MNX1 ESRRB ZBTB4 GATA4 GSX2 ZNF784 YY1 MEF2C NFE2L3 JUN JUNB JUND FOXP4 PURA ZBTB10 ZFHX2 ONECUT3 DMRT1 PBX2 PBX3 FOXK1 MAF | 1.34e-07 | 1412 | 117 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX2 SOX3 TCF4 ZNF628 ESRRB ZBTB4 GATA4 ZNF784 YY1 MEF2C NFE2L3 JUN JUNB JUND FOXP4 SAFB ZFHX2 SUZ12 ONECUT3 DMRT1 PBX2 PBX3 FOXK1 MAF | 1.92e-07 | 1244 | 117 | 24 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX2 SOX3 TCF4 ZNF628 ESRRB ZBTB4 GATA4 ZNF784 YY1 MEF2C NFE2L3 JUN JUNB JUND FOXP4 SAFB PURA ZBTB10 ZFHX2 SUZ12 ONECUT3 DMRT1 PBX2 PBX3 FOXK1 MAF | 2.54e-07 | 1459 | 117 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX2 SOX3 TCF4 ZNF628 ESRRB ZBTB4 GATA4 ZNF784 YY1 MEF2C NFE2L3 JUN JUNB JUND FOXP4 SAFB ZFHX2 SUZ12 ONECUT3 DMRT1 PBX2 PBX3 FOXK1 MAF | 2.84e-07 | 1271 | 117 | 24 | GO:0000987 |
| GeneOntologyMolecularFunction | transcription factor binding | SOX2 TCF4 IRF2BP1 MED29 ESRRB GATA4 CXXC5 YY1 MEF2C YEATS2 JUN JUNB JUND IFRD1 PURA SUZ12 PBX2 | 1.85e-06 | 753 | 117 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | chromatin binding | SOX2 TCF4 GATA4 YY1 MEF2C JUN ARID1B SAFB SMARCC1 SUZ12 RERE TAF5 DMRT1 PBX2 CRAMP1 | 2.75e-05 | 739 | 117 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 RYR1 CDH24 ASTN2 PCDHGC3 | 3.21e-05 | 749 | 117 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.13e-04 | 320 | 117 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.30e-04 | 326 | 117 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SOX2 TCF4 ESRRB GATA4 CXXC5 YY1 MEF2C JUN JUND IFRD1 PURA PBX2 | 1.59e-04 | 582 | 117 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | epinephrine binding | 5.03e-04 | 6 | 117 | 2 | GO:0051379 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 1.19e-03 | 9 | 117 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.64e-03 | 86 | 117 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | TCF4 IRF2BP1 MED29 SAP30 YEATS2 JUND TSC22D1 ARID1B SMARCC1 RERE | 1.74e-03 | 562 | 117 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.19e-03 | 93 | 117 | 4 | GO:0097110 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 TRO PCDHGA1 CDH24 PCDHGC3 | 2.49e-12 | 187 | 115 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FNIP2 SOX2 SOX3 TCF4 RBM15 IRF2BP1 MNX1 TRO ZBTB4 GATA4 CXXC5 YY1 MEF2C SAP30 NFE2L3 YEATS2 JUN JUND FOXP4 MAGED2 PURA ZBTB10 SUZ12 DMRT1 FOXK1 MAF | 1.06e-10 | 1053 | 115 | 26 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FNIP2 SOX2 SOX3 TCF4 RBM15 IRF2BP1 MNX1 TRO ESRRB ZBTB4 GATA4 CXXC5 YY1 MEF2C SAP30 NFE2L3 YEATS2 JUN JUND FOXP4 MAGED2 PURA ZBTB10 SUZ12 RERE DMRT1 FOXK1 MAF | 2.10e-09 | 1399 | 115 | 28 | GO:0045892 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 TRO PCDHGA1 CDH24 PCDHGC3 | 2.31e-09 | 313 | 115 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FNIP2 SOX2 SOX3 TCF4 RBM15 IRF2BP1 MNX1 TRO ESRRB ZBTB4 GATA4 CXXC5 YY1 MEF2C SAP30 NFE2L3 YEATS2 JUN JUND FOXP4 MAGED2 PURA ZBTB10 SUZ12 RERE DMRT1 FOXK1 MAF | 2.62e-09 | 1413 | 115 | 28 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX2 SOX3 TCF4 RBM15 MED29 ESRRB GATA4 ZNF784 YY1 MEF2C GSK3A JUN JUNB JUND TSC22D1 IFRD1 TAF8 SAFB CDK13 SMARCC1 TAF5 ONECUT3 DMRT1 PBX2 PBX3 AGAP2 MAF | 8.25e-09 | 1390 | 115 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SOX2 PDE4D PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 TRO PCDHGA1 CDH24 ARID1B SMARCC1 ASTN2 PCDHGC3 | 7.64e-06 | 1077 | 115 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.34e-04 | 88 | 115 | 5 | GO:0071277 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SOX2 TCF4 RBM15 MED29 YY1 GSK3A YEATS2 TAF8 ARID1B SAFB GATAD1 SMARCC1 EEF1AKMT2 SUZ12 RERE TAF5 | 1.34e-04 | 999 | 115 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | integrated stress response signaling | 1.60e-04 | 49 | 115 | 4 | GO:0140467 | |
| GeneOntologyBiologicalProcess | regulation of system process | SHANK1 DRD4 PDE4D GATA4 GSX2 YY1 MEF2C GSK3A RYR1 ADRA2C KCNN2 ZFHX2 PBX3 | 2.29e-04 | 734 | 115 | 13 | GO:0044057 |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 2.30e-04 | 219 | 115 | 7 | GO:0071248 | |
| GeneOntologyCellularComponent | chromatin | SOX2 SOX3 TCF4 MNX1 ESRRB GATA4 GSX2 YY1 MEF2C SAP30 NFE2L3 YEATS2 JUN JUNB JUND FOXP4 ARID1B SMARCC1 ZFHX2 SUZ12 TAF5 ONECUT3 DMRT1 PBX2 PBX3 FOXK1 MAF | 3.44e-08 | 1480 | 117 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | SOX2 TCF4 MED29 GATA4 YY1 NFE2L3 JUN JUNB JUND TAF8 TAF5 ONECUT3 PBX2 PBX3 MAF | 1.21e-06 | 596 | 117 | 15 | GO:0005667 |
| GeneOntologyCellularComponent | transcription factor AP-1 complex | 1.69e-06 | 5 | 117 | 3 | GO:0035976 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.10e-06 | 272 | 117 | 10 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TCF4 MED29 ESRRB GATA4 YY1 SAP30 NFE2L3 BOD1 JUN JUNB JUND TAF8 ARID1B CDK13 SMARCC1 SUZ12 RERE TAF5 COPS6 MAF | 7.49e-05 | 1377 | 117 | 20 | GO:0140513 |
| Domain | Cadherin_tail | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 1.90e-14 | 37 | 117 | 10 | PF15974 |
| Domain | Cadherin_CBD | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 1.90e-14 | 37 | 117 | 10 | IPR031904 |
| Domain | Cadherin_C | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 7.82e-14 | 42 | 117 | 10 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 7.82e-14 | 42 | 117 | 10 | PF16492 |
| Domain | Cadherin_CS | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 1.63e-13 | 109 | 117 | 13 | IPR020894 |
| Domain | CADHERIN_1 | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 2.63e-13 | 113 | 117 | 13 | PS00232 |
| Domain | Cadherin | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 2.63e-13 | 113 | 117 | 13 | PF00028 |
| Domain | CADHERIN_2 | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 2.95e-13 | 114 | 117 | 13 | PS50268 |
| Domain | - | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 2.95e-13 | 114 | 117 | 13 | 2.60.40.60 |
| Domain | CA | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 3.31e-13 | 115 | 117 | 13 | SM00112 |
| Domain | Cadherin-like | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 3.71e-13 | 116 | 117 | 13 | IPR015919 |
| Domain | Cadherin | PCDHGC5 PCDHGB7 PCDHGB6 DSG1 PCDHGB3 DSG3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CDH24 PCDHGC3 | 4.64e-13 | 118 | 117 | 13 | IPR002126 |
| Domain | Cadherin_2 | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 8.44e-12 | 65 | 117 | 10 | PF08266 |
| Domain | Cadherin_N | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 8.44e-12 | 65 | 117 | 10 | IPR013164 |
| Domain | - | 3.66e-08 | 16 | 117 | 5 | 1.10.880.10 | |
| Domain | Jun | 2.40e-07 | 3 | 117 | 3 | PF03957 | |
| Domain | JNK | 2.40e-07 | 3 | 117 | 3 | IPR005643 | |
| Domain | Leuzip_Jun | 2.40e-07 | 3 | 117 | 3 | IPR002112 | |
| Domain | TF_DNA-bd | 3.29e-06 | 37 | 117 | 5 | IPR008917 | |
| Domain | BRLZ | 1.82e-05 | 52 | 117 | 5 | SM00338 | |
| Domain | BZIP | 2.00e-05 | 53 | 117 | 5 | PS50217 | |
| Domain | BZIP_BASIC | 2.00e-05 | 53 | 117 | 5 | PS00036 | |
| Domain | bZIP | 2.19e-05 | 54 | 117 | 5 | IPR004827 | |
| Domain | bZIP_1 | 5.87e-05 | 34 | 117 | 4 | PF00170 | |
| Domain | Znf_GATA | 1.03e-04 | 15 | 117 | 3 | IPR000679 | |
| Domain | GATA | 1.03e-04 | 15 | 117 | 3 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 1.26e-04 | 16 | 117 | 3 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 1.26e-04 | 16 | 117 | 3 | PS50114 | |
| Domain | Desmoglein | 2.32e-04 | 4 | 117 | 2 | IPR009123 | |
| Domain | PBC | 2.32e-04 | 4 | 117 | 2 | PF03792 | |
| Domain | PBX | 2.32e-04 | 4 | 117 | 2 | IPR005542 | |
| Domain | Homeodomain-like | 2.44e-04 | 332 | 117 | 9 | IPR009057 | |
| Domain | SOXp | 3.84e-04 | 5 | 117 | 2 | PF12336 | |
| Domain | SOX_fam | 3.84e-04 | 5 | 117 | 2 | IPR022097 | |
| Domain | - | 4.47e-04 | 57 | 117 | 4 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.78e-04 | 58 | 117 | 4 | IPR013088 | |
| Domain | Cadherin_cytoplasmic-dom | 4.98e-04 | 25 | 117 | 3 | IPR000233 | |
| Domain | Cadherin_C | 4.98e-04 | 25 | 117 | 3 | PF01049 | |
| Domain | SANT_dom | 5.61e-04 | 26 | 117 | 3 | IPR017884 | |
| Domain | SANT | 7.00e-04 | 28 | 117 | 3 | PS51293 | |
| Domain | Catenin_binding_dom | 7.77e-04 | 29 | 117 | 3 | IPR027397 | |
| Domain | - | 7.77e-04 | 29 | 117 | 3 | 4.10.900.10 | |
| Domain | Desmosomal_cadherin | 8.00e-04 | 7 | 117 | 2 | IPR009122 | |
| Domain | - | 2.05e-03 | 283 | 117 | 7 | 1.10.10.60 | |
| Domain | ZnF_GATA | 2.46e-03 | 12 | 117 | 2 | SM00401 | |
| Domain | bZIP_Maf | 2.90e-03 | 13 | 117 | 2 | IPR004826 | |
| Domain | bZIP_Maf | 2.90e-03 | 13 | 117 | 2 | PF03131 | |
| Domain | Homeobox | 3.57e-03 | 234 | 117 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.73e-03 | 236 | 117 | 6 | PS00027 | |
| Domain | SANT | 3.79e-03 | 50 | 117 | 3 | SM00717 | |
| Domain | HOX | 3.80e-03 | 237 | 117 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 3.96e-03 | 239 | 117 | 6 | PS50071 | |
| Domain | Homeobox_dom | 3.96e-03 | 239 | 117 | 6 | IPR001356 | |
| Domain | SANT/Myb | 4.24e-03 | 52 | 117 | 3 | IPR001005 | |
| Domain | Homeobox_CS | 6.34e-03 | 186 | 117 | 5 | IPR017970 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SOX2 KRT5 TCF4 RASA1 MED29 DSG1 DSG3 GATA4 TNRC6B PSMD8 YY1 MEF2C JUN TSC22D1 ARID1B SMARCC1 SUZ12 ONECUT3 DMRT1 KRT25 AGAP2 | 1.44e-05 | 1432 | 76 | 21 | M509 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX2 SOX3 TCF4 MNX1 ESRRB ZBTB4 GATA4 GSX2 YY1 MEF2C NFE2L3 YEATS2 JUN JUNB JUND FOXP4 TSC22D1 GATAD1 ZFHX2 RERE ONECUT3 DMRT1 PBX2 PBX3 CRAMP1 FOXK1 MAF | 4.10e-18 | 908 | 118 | 27 | 19274049 |
| Pubmed | SOX2 TCF4 IRF2BP1 MNX1 GATA4 CCDC85C TNRC6B PSMD8 YY1 MEF2C YEATS2 JUN JUNB JUND FOXP4 TAF8 ARID1B MAGED2 PURA ZBTB10 GATAD1 SMARCC1 RPRD2 RERE TAF5 PBX2 PUM1 CAPRIN1 FOXK1 | 4.48e-15 | 1429 | 118 | 29 | 35140242 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 3.37e-14 | 68 | 118 | 10 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 6.15e-14 | 72 | 118 | 10 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 8.20e-14 | 74 | 118 | 10 | 10817752 |
| Pubmed | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 1.24e-13 | 77 | 118 | 10 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 1.85e-13 | 80 | 118 | 10 | 10716726 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SOX3 TCF4 MNX1 ESRRB GATA4 GSX2 ZNF784 YY1 MEF2C JUN JUNB JUND ONECUT3 DMRT1 FOXK1 MAF | 5.54e-11 | 544 | 118 | 16 | 28473536 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 TRO GATA4 PSMD8 BEND4 YY1 MEF2C SAP30 JUN JUNB JUND FOXP4 IFRD1 ZBTB10 SMARCC1 PBX2 PUM1 PBX3 FOXK1 | 9.50e-11 | 857 | 118 | 19 | 25609649 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SOX2 TCF4 IRF2BP1 GATA4 GSX2 YY1 MEF2C SAP30 JUN JUNB JUND PURA GATAD1 SUZ12 RERE TAF5 DMRT1 PBX2 PBX3 | 1.40e-10 | 877 | 118 | 19 | 20211142 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE4D RASA1 CXXC5 CCDC85C TNRC6B ZSWIM6 YEATS2 FOXP4 TSC22D1 IFRD1 GPR137C CDK13 PURA KCNN2 ZFHX2 ASTN2 RPRD2 RERE PBX2 PBX3 CRAMP1 FAM149A MAF | 1.00e-09 | 1489 | 118 | 23 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEC16B RBM15 YY1 SAP30 GSK3A YEATS2 JUN JUNB JUND SAFB MAGED2 CDK13 EIF4G2 SMARCC1 SUZ12 RERE MN1 | 1.17e-09 | 774 | 118 | 17 | 15302935 |
| Pubmed | 1.21e-09 | 15 | 118 | 5 | 23515096 | ||
| Pubmed | IRF2-binding protein-1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2-dependent transcription. | 4.37e-09 | 7 | 118 | 4 | 18671972 | |
| Pubmed | 8.52e-09 | 44 | 118 | 6 | 19029045 | ||
| Pubmed | SOX2 TCF4 MNX1 ESRRB MEF2C JUN JUND FOXP4 SMARCC1 ZFHX2 PJA1 PBX2 PBX3 COPS6 FOXK1 | 1.96e-08 | 709 | 118 | 15 | 22988430 | |
| Pubmed | RBM15 UBQLN1 IRF2BP1 MED29 DNAJC8 YY1 YEATS2 ZC3H10 JUN JUNB JUND ARID1B SAFB CDK13 EIF4G2 SMARCC1 CAPRIN1 FOXK1 | 3.62e-08 | 1103 | 118 | 18 | 34189442 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 1793595 | ||
| Pubmed | DNA binding activities of three murine Jun proteins: stimulation by Fos. | 3.81e-08 | 3 | 118 | 3 | 3142691 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 2104845 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 3.81e-08 | 28 | 118 | 5 | 15347688 | |
| Pubmed | KRT5 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 TRO PCDHGA1 PSMD8 YY1 NFE2L3 SAFB MAGED2 CDK13 SMARCC1 PCDHGC3 AGAP2 | 8.37e-08 | 1442 | 118 | 20 | 35575683 | |
| Pubmed | 9.08e-08 | 33 | 118 | 5 | 20102225 | ||
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 1.06e-07 | 34 | 118 | 5 | 22884324 | |
| Pubmed | SOX2 SOX3 TCF4 ESRRB GATA4 YY1 ZC3H10 JUN JUNB TSC22D1 SMARCC1 DMRT1 PBX2 PBX3 FOXK1 | 1.07e-07 | 808 | 118 | 15 | 20412781 | |
| Pubmed | c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. | 1.52e-07 | 4 | 118 | 3 | 8945519 | |
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 19587266 | ||
| Pubmed | Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. | 1.52e-07 | 4 | 118 | 3 | 9154808 | |
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 12080089 | ||
| Pubmed | Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. | 1.52e-07 | 4 | 118 | 3 | 17681951 | |
| Pubmed | 2.22e-07 | 16 | 118 | 4 | 15867431 | ||
| Pubmed | 3.08e-07 | 263 | 118 | 9 | 20932939 | ||
| Pubmed | 3.60e-07 | 268 | 118 | 9 | 33640491 | ||
| Pubmed | Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. | 3.71e-07 | 18 | 118 | 4 | 19303854 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 1605850 | ||
| Pubmed | Biphasic regulation of AP-1 subunits during human epidermal wound healing. | 3.79e-07 | 5 | 118 | 3 | 17495958 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 8617242 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 12165517 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 15507668 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 17510411 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RBM15 MED29 CXXC5 YY1 SAP30 YEATS2 JUN JUNB JUND SAFB CDK13 EIF4G2 GATAD1 SMARCC1 RPRD2 SUZ12 TAF5 FOXK1 | 3.85e-07 | 1294 | 118 | 18 | 30804502 |
| Pubmed | 4.09e-07 | 83 | 118 | 6 | 28794006 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | KRT5 RBM15 MNX1 TNRC6B SAP30 YEATS2 JUN JUNB ARID1B PURA SMARCC1 PJA1 MAP3K21 PUM1 PBX3 | 5.73e-07 | 922 | 118 | 15 | 27609421 |
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 9872330 | ||
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 8570175 | ||
| Pubmed | Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development. | 7.56e-07 | 6 | 118 | 3 | 7700631 | |
| Pubmed | Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1. | 7.56e-07 | 6 | 118 | 3 | 10508860 | |
| Pubmed | Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. | 7.56e-07 | 6 | 118 | 3 | 24029232 | |
| Pubmed | 8.78e-07 | 22 | 118 | 4 | 28566324 | ||
| Pubmed | UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | 1.06e-06 | 155 | 118 | 7 | 34921745 | |
| Pubmed | Genetic mapping in the mouse of four loci related to the jun family of transcriptional activators. | 1.32e-06 | 7 | 118 | 3 | 1887331 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 20235171 | ||
| Pubmed | Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man. | 1.32e-06 | 7 | 118 | 3 | 2108401 | |
| Pubmed | Smads bind directly to the Jun family of AP-1 transcription factors. | 1.32e-06 | 7 | 118 | 3 | 10220381 | |
| Pubmed | Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. | 1.32e-06 | 7 | 118 | 3 | 11477071 | |
| Pubmed | 1.37e-06 | 407 | 118 | 10 | 12693553 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.50e-06 | 57 | 118 | 5 | 32633719 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.75e-06 | 167 | 118 | 7 | 20362541 | |
| Pubmed | 2.11e-06 | 8 | 118 | 3 | 26747248 | ||
| Pubmed | 2.11e-06 | 8 | 118 | 3 | 21937452 | ||
| Pubmed | Selective interaction of JNK protein kinase isoforms with transcription factors. | 2.11e-06 | 8 | 118 | 3 | 8654373 | |
| Pubmed | Sox2 induces neuronal formation in the developing mammalian cochlea. | 3.15e-06 | 9 | 118 | 3 | 20071536 | |
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 12154121 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.34e-06 | 351 | 118 | 9 | 38297188 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.13e-06 | 123 | 118 | 6 | 26912792 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 22087235 | ||
| Pubmed | Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. | 4.49e-06 | 10 | 118 | 3 | 24411941 | |
| Pubmed | DNAJC8 TNRC6B PSMD8 YEATS2 JUN JUNB ARID1B SAFB RPRD2 CAPRIN1 | 5.09e-06 | 472 | 118 | 10 | 38943005 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 ZNF628 ZBTB4 IRS1 SAP30 RYR1 JUN JUNB JUND CDK13 SUMF1 PUM1 CRAMP1 FOXK1 AHNAK2 | 5.27e-06 | 1105 | 118 | 15 | 35748872 |
| Pubmed | 5.68e-06 | 130 | 118 | 6 | 19386638 | ||
| Pubmed | 5.73e-06 | 282 | 118 | 8 | 23667531 | ||
| Pubmed | 7.63e-06 | 37 | 118 | 4 | 24335282 | ||
| Pubmed | Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. | 8.19e-06 | 12 | 118 | 3 | 24268575 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 39226364 | ||
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 34234180 | ||
| Pubmed | Neuronal migration and ventral subtype identity in the telencephalon depend on SOX1. | 8.19e-06 | 12 | 118 | 3 | 15882093 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 20573694 | ||
| Pubmed | Networks of bZIP protein-protein interactions diversified over a billion years of evolution. | 1.05e-05 | 40 | 118 | 4 | 23661758 | |
| Pubmed | SOX2-LIN28/let-7 pathway regulates proliferation and neurogenesis in neural precursors. | 1.06e-05 | 13 | 118 | 3 | 23884650 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 32675174 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 26523946 | ||
| Pubmed | Glucocorticoid receptor is required for skin barrier competence. | 1.06e-05 | 13 | 118 | 3 | 18039792 | |
| Pubmed | Isolation of human cDNA clones of jun-related genes, jun-B and jun-D. | 1.14e-05 | 2 | 118 | 2 | 2112242 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28620161 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28951524 | ||
| Pubmed | Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes. | 1.14e-05 | 2 | 118 | 2 | 1899335 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28754779 | ||
| Pubmed | MEF2C loss-of-function mutation contributes to congenital heart defects. | 1.14e-05 | 2 | 118 | 2 | 29104469 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36183833 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 38891067 | ||
| Pubmed | GATA-dependent recruitment of MEF2 proteins to target promoters. | 1.14e-05 | 2 | 118 | 2 | 10790371 | |
| Pubmed | Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. | 1.14e-05 | 2 | 118 | 2 | 19995970 | |
| Pubmed | Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. | 1.14e-05 | 2 | 118 | 2 | 12485422 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31020615 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21393445 | ||
| Pubmed | Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. | 1.14e-05 | 2 | 118 | 2 | 2917002 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8197114 | ||
| Pubmed | Identification and Validation of a Putative Polycomb Responsive Element in the Human Genome. | 1.14e-05 | 2 | 118 | 2 | 23805300 | |
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 1.14e-05 | 2 | 118 | 2 | 8186414 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21289643 | ||
| Interaction | PCDHGB2 interactions | 5.95e-09 | 44 | 117 | 7 | int:PCDHGB2 | |
| Interaction | FEV interactions | 3.01e-07 | 203 | 117 | 10 | int:FEV | |
| Interaction | ELK3 interactions | 4.96e-07 | 120 | 117 | 8 | int:ELK3 | |
| Interaction | H2BC5 interactions | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 YY1 SMARCC1 PCDHGC3 | 5.18e-07 | 331 | 117 | 12 | int:H2BC5 |
| Interaction | HDAC2 interactions | SOX2 KRT5 ESRRB GATA4 IRS1 YY1 SAP30 IFRD1 MAGED2 EIF4G2 GATAD1 SMARCC1 RPRD2 SUZ12 RERE CAPRIN1 FOXK1 AHNAK2 MAF | 5.62e-07 | 865 | 117 | 19 | int:HDAC2 |
| Interaction | PCDHA9 interactions | 1.08e-06 | 32 | 117 | 5 | int:PCDHA9 | |
| Interaction | CRX interactions | 2.32e-06 | 254 | 117 | 10 | int:CRX | |
| Interaction | ASH2L interactions | 3.38e-06 | 265 | 117 | 10 | int:ASH2L | |
| Interaction | NFE2L1 interactions | 6.14e-06 | 45 | 117 | 5 | int:NFE2L1 | |
| Interaction | SOX2 interactions | SOX2 SOX3 KRT5 RBM15 PDE4D IRF2BP1 DSG3 MNX1 ESRRB GATA4 YY1 MEF2C RYR1 JUN JUND FOXP4 ARID1B MAGED2 ZBTB10 SMARCC1 PBX2 CAPRIN1 FOXK1 | 6.23e-06 | 1422 | 117 | 23 | int:SOX2 |
| Interaction | NFIX interactions | 7.17e-06 | 227 | 117 | 9 | int:NFIX | |
| Interaction | MTA3 interactions | 7.72e-06 | 173 | 117 | 8 | int:MTA3 | |
| Interaction | TLX1 interactions | 8.40e-06 | 175 | 117 | 8 | int:TLX1 | |
| Interaction | BRMS1L interactions | 8.41e-06 | 125 | 117 | 7 | int:BRMS1L | |
| Interaction | SALL4 interactions | 8.83e-06 | 83 | 117 | 6 | int:SALL4 | |
| Interaction | PCDHGB3 interactions | 1.05e-05 | 8 | 117 | 3 | int:PCDHGB3 | |
| Interaction | TP63 interactions | 1.13e-05 | 304 | 117 | 10 | int:TP63 | |
| Interaction | SIN3A interactions | SOX2 ZBTB4 YY1 SAP30 GATAD1 SMARCC1 SUZ12 PBX3 COPS6 FOXK1 MAF | 1.35e-05 | 380 | 117 | 11 | int:SIN3A |
| Interaction | FOS interactions | 1.42e-05 | 312 | 117 | 10 | int:FOS | |
| Interaction | BATF3 interactions | 1.53e-05 | 54 | 117 | 5 | int:BATF3 | |
| Interaction | EP300 interactions | SOX2 TCF4 RBM15 UBQLN1 GATA4 PSMD8 ZNF784 YY1 MEF2C JUN JUNB JUND IFRD1 SAFB PURA SMARCC1 RERE PUM1 COPS6 MN1 FOXK1 MAF | 1.63e-05 | 1401 | 117 | 22 | int:EP300 |
| Interaction | BPTF interactions | 1.99e-05 | 197 | 117 | 8 | int:BPTF | |
| Interaction | HNF4A interactions | 3.29e-05 | 275 | 117 | 9 | int:HNF4A | |
| Interaction | TAF9 interactions | 4.00e-05 | 159 | 117 | 7 | int:TAF9 | |
| Interaction | SMARCC2 interactions | SOX2 TCF4 ESRRB GATA4 SAP30 JUN ARID1B SMARCC1 SUZ12 CAPRIN1 | 4.06e-05 | 353 | 117 | 10 | int:SMARCC2 |
| Interaction | PCDHGA4 interactions | 4.37e-05 | 34 | 117 | 4 | int:PCDHGA4 | |
| Interaction | LIN9 interactions | 4.64e-05 | 111 | 117 | 6 | int:LIN9 | |
| Interaction | NCOA3 interactions | 4.96e-05 | 224 | 117 | 8 | int:NCOA3 | |
| Interaction | HIRA interactions | 5.06e-05 | 165 | 117 | 7 | int:HIRA | |
| Interaction | HCFC1 interactions | 5.38e-05 | 293 | 117 | 9 | int:HCFC1 | |
| Interaction | SAP30 interactions | 5.46e-05 | 167 | 117 | 7 | int:SAP30 | |
| Interaction | PAX6 interactions | 5.50e-05 | 366 | 117 | 10 | int:PAX6 | |
| Interaction | SMAD3 interactions | GATA4 CXXC5 IRS1 YY1 JUN JUNB JUND ARID1B SMARCC1 SUZ12 PJA1 | 5.94e-05 | 447 | 117 | 11 | int:SMAD3 |
| Interaction | SP7 interactions | 7.14e-05 | 304 | 117 | 9 | int:SP7 | |
| Interaction | MEF2A interactions | 8.05e-05 | 76 | 117 | 5 | int:MEF2A | |
| Interaction | SMAD2 interactions | 8.37e-05 | 385 | 117 | 10 | int:SMAD2 | |
| Interaction | TAF6 interactions | 9.28e-05 | 245 | 117 | 8 | int:TAF6 | |
| Interaction | GATAD2B interactions | 9.28e-05 | 245 | 117 | 8 | int:GATAD2B | |
| Interaction | JUND interactions | 9.68e-05 | 79 | 117 | 5 | int:JUND | |
| Interaction | CEBPA interactions | RBM15 UBQLN1 IRF2BP1 MED29 DNAJC8 YY1 YEATS2 ZC3H10 JUN JUNB JUND ARID1B SAFB CDK13 EIF4G2 SMARCC1 CAPRIN1 FOXK1 MAF | 9.78e-05 | 1245 | 117 | 19 | int:CEBPA |
| Interaction | CTRB2 interactions | 9.99e-05 | 3 | 117 | 2 | int:CTRB2 | |
| Interaction | JDP2 interactions | 1.02e-04 | 42 | 117 | 4 | int:JDP2 | |
| Interaction | PAX9 interactions | 1.12e-04 | 130 | 117 | 6 | int:PAX9 | |
| Interaction | PKNOX1 interactions | 1.16e-04 | 82 | 117 | 5 | int:PKNOX1 | |
| Interaction | TNIP2 interactions | KRT5 RBM15 MNX1 TRO TNRC6B SAP30 YEATS2 JUN JUNB ARID1B PURA SMARCC1 PJA1 MAP3K21 PUM1 PBX3 | 1.24e-04 | 952 | 117 | 16 | int:TNIP2 |
| Interaction | CHD3 interactions | SOX2 KRT5 RBM15 DSG1 YY1 SAP30 JUN TSC22D1 SAFB EIF4G2 GATAD1 SMARCC1 SUZ12 CAPRIN1 | 1.27e-04 | 757 | 117 | 14 | int:CHD3 |
| Interaction | KLF5 interactions | 1.44e-04 | 195 | 117 | 7 | int:KLF5 | |
| Interaction | SS18 interactions | 1.61e-04 | 88 | 117 | 5 | int:SS18 | |
| Interaction | TAF3 interactions | 1.61e-04 | 88 | 117 | 5 | int:TAF3 | |
| Interaction | PPP1R13L interactions | 1.61e-04 | 88 | 117 | 5 | int:PPP1R13L | |
| Interaction | FOSB interactions | 1.87e-04 | 49 | 117 | 4 | int:FOSB | |
| Interaction | BEND4 interactions | 1.99e-04 | 4 | 117 | 2 | int:BEND4 | |
| Interaction | ZCWPW2 interactions | 1.99e-04 | 4 | 117 | 2 | int:ZCWPW2 | |
| Interaction | UBA7 interactions | 2.02e-04 | 20 | 117 | 3 | int:UBA7 | |
| Interaction | HDAC1 interactions | SOX2 ESRRB GATA4 CCDC85C TNRC6B YY1 SAP30 GSK3A YEATS2 JUN IFRD1 GATAD1 SMARCC1 SUZ12 RERE CAPRIN1 FOXK1 | 2.22e-04 | 1108 | 117 | 17 | int:HDAC1 |
| Interaction | MLLT6 interactions | 2.31e-04 | 95 | 117 | 5 | int:MLLT6 | |
| Interaction | BCL7B interactions | 2.31e-04 | 95 | 117 | 5 | int:BCL7B | |
| Interaction | MEF2C interactions | 2.73e-04 | 54 | 117 | 4 | int:MEF2C | |
| Interaction | RBBP5 interactions | 2.74e-04 | 287 | 117 | 8 | int:RBBP5 | |
| Interaction | NUP43 interactions | RBM15 DSG1 MUC19 TNRC6B YEATS2 ARID1B SAFB EIF4G2 ZBTB10 SMARCC1 RERE AHNAK2 | 2.81e-04 | 625 | 117 | 12 | int:NUP43 |
| Interaction | ACTL6A interactions | 2.87e-04 | 289 | 117 | 8 | int:ACTL6A | |
| Interaction | ELF2 interactions | 3.01e-04 | 156 | 117 | 6 | int:ELF2 | |
| Interaction | CDK4 interactions | 3.08e-04 | 292 | 117 | 8 | int:CDK4 | |
| Interaction | YY1 interactions | 3.18e-04 | 454 | 117 | 10 | int:YY1 | |
| Interaction | ERG interactions | 3.27e-04 | 223 | 117 | 7 | int:ERG | |
| Interaction | MBD3 interactions | 3.29e-04 | 295 | 117 | 8 | int:MBD3 | |
| Interaction | GATAD2A interactions | 3.36e-04 | 224 | 117 | 7 | int:GATAD2A | |
| Interaction | ING1 interactions | 3.37e-04 | 103 | 117 | 5 | int:ING1 | |
| Interaction | MYCN interactions | KRT5 TCF4 RBM15 DSG1 DNAJC8 TNRC6B YY1 SAP30 ZC3H10 JUNB ARID1B SAFB CDK13 PURA SMARCC1 SUZ12 PBX3 CAPRIN1 FOXK1 | 3.43e-04 | 1373 | 117 | 19 | int:MYCN |
| Interaction | BACC1 interactions | 3.52e-04 | 104 | 117 | 5 | int:BACC1 | |
| Interaction | BATF interactions | 3.53e-04 | 24 | 117 | 3 | int:BATF | |
| Interaction | PCDHGA6 interactions | 3.53e-04 | 24 | 117 | 3 | int:PCDHGA6 | |
| Interaction | KDM6A interactions | 3.69e-04 | 162 | 117 | 6 | int:KDM6A | |
| Interaction | MED26 interactions | 4.02e-04 | 107 | 117 | 5 | int:MED26 | |
| Interaction | SMARCC1 interactions | 4.08e-04 | 384 | 117 | 9 | int:SMARCC1 | |
| Interaction | LHX4 interactions | 4.20e-04 | 166 | 117 | 6 | int:LHX4 | |
| Interaction | TCL1A interactions | 4.36e-04 | 61 | 117 | 4 | int:TCL1A | |
| Interaction | FUBP1 interactions | 4.48e-04 | 309 | 117 | 8 | int:FUBP1 | |
| Interaction | ID3 interactions | 4.64e-04 | 62 | 117 | 4 | int:ID3 | |
| Interaction | HDAC3 interactions | 4.88e-04 | 313 | 117 | 8 | int:HDAC3 | |
| Interaction | PCDHGB7 interactions | 4.94e-04 | 6 | 117 | 2 | int:PCDHGB7 | |
| Interaction | EHMT2 interactions | 5.09e-04 | 315 | 117 | 8 | int:EHMT2 | |
| Interaction | CYLD interactions | KRT5 UBQLN1 DSG1 MUC19 CCDC85C TNRC6B GSK3A YEATS2 JUN FOXP4 MAGED2 EIF4G2 CAPRIN1 KRT25 | 5.09e-04 | 868 | 117 | 14 | int:CYLD |
| Interaction | HMGXB4 interactions | 5.16e-04 | 113 | 117 | 5 | int:HMGXB4 | |
| Interaction | MTCL2 interactions | 5.37e-04 | 114 | 117 | 5 | int:MTCL2 | |
| Interaction | SMG7 interactions | 5.53e-04 | 319 | 117 | 8 | int:SMG7 | |
| Interaction | CEBPG interactions | 5.56e-04 | 65 | 117 | 4 | int:CEBPG | |
| Interaction | ATF1 interactions | 5.56e-04 | 65 | 117 | 4 | int:ATF1 | |
| Interaction | TEAD1 interactions | 5.72e-04 | 176 | 117 | 6 | int:TEAD1 | |
| Interaction | TAF2 interactions | 6.07e-04 | 178 | 117 | 6 | int:TAF2 | |
| Interaction | JUNB interactions | 6.28e-04 | 118 | 117 | 5 | int:JUNB | |
| Interaction | UNK interactions | UBQLN1 CCDC85C TNRC6B GSK3A TSC22D1 SAFB EIF4G2 PUM1 CAPRIN1 | 6.30e-04 | 408 | 117 | 9 | int:UNK |
| Interaction | DLGAP1 interactions | 6.44e-04 | 180 | 117 | 6 | int:DLGAP1 | |
| Interaction | ING2 interactions | 6.60e-04 | 68 | 117 | 4 | int:ING2 | |
| Interaction | KLF8 interactions | 6.76e-04 | 329 | 117 | 8 | int:KLF8 | |
| Interaction | DDIT3 interactions | 6.78e-04 | 120 | 117 | 5 | int:DDIT3 | |
| Interaction | PCDHGB6 interactions | 6.89e-04 | 7 | 117 | 2 | int:PCDHGB6 | |
| Interaction | CTRB1 interactions | 6.89e-04 | 7 | 117 | 2 | int:CTRB1 | |
| Interaction | ETS1 interactions | 7.04e-04 | 121 | 117 | 5 | int:ETS1 | |
| Interaction | CREB1 interactions | 7.11e-04 | 254 | 117 | 7 | int:CREB1 | |
| Cytoband | 5q31 | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PURA PCDHGC3 | 1.14e-14 | 115 | 118 | 11 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 CXXC5 PURA PCDHGC3 | 2.07e-11 | 298 | 118 | 12 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 6.05e-13 | 64 | 89 | 10 | 20 |
| GeneFamily | Basic leucine zipper proteins|Jun transcription factor family | 1.15e-07 | 3 | 89 | 3 | 1257 | |
| GeneFamily | Basic leucine zipper proteins | 4.15e-06 | 49 | 89 | 5 | 506 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.03e-05 | 15 | 89 | 3 | 82 | |
| GeneFamily | Desmosomal cadherins | 4.95e-04 | 7 | 89 | 2 | 1188 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.26e-03 | 53 | 89 | 3 | 532 | |
| GeneFamily | SRY-boxes | 3.88e-03 | 19 | 89 | 2 | 757 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 5.48e-06 | 212 | 118 | 8 | MM3816 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_DN | 7.61e-06 | 60 | 118 | 5 | M7735 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_DN | 8.26e-06 | 61 | 118 | 5 | MM790 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | TCF4 INAFM2 MED29 ZBTB4 TNRC6B IRS1 JUN JUND TSC22D1 ARID1B CDK13 PURA RERE MAF | 1.66e-05 | 807 | 118 | 14 | M16651 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_DN | 2.15e-05 | 256 | 118 | 8 | M828 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D8 | 2.30e-05 | 37 | 118 | 4 | M15693 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | SOX2 KRT5 TCF4 CTRB2 PSMD8 YY1 YEATS2 JUNB JUND GATAD1 SMARCC1 CTRB1 MN1 | 2.34e-05 | 723 | 118 | 13 | MM3672 |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN | 2.88e-05 | 194 | 118 | 7 | M7580 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_DELTA_CELL_AGEING | 3.50e-05 | 200 | 118 | 7 | MM3817 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 3.50e-05 | 200 | 118 | 7 | M8854 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_ALPHA_CELL_AGEING | 4.55e-05 | 142 | 118 | 6 | MM3815 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 5.21e-05 | 290 | 118 | 8 | M17183 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 6.77e-05 | 222 | 118 | 7 | M16955 | |
| Coexpression | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN | 7.07e-05 | 49 | 118 | 4 | M10389 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS | 8.18e-05 | 19 | 118 | 3 | M39272 | |
| Coexpression | BENPORATH_SOX2_TARGETS | SOX2 RASA1 SAP30 GSK3A NFE2L3 TSC22D1 ARID1B MAGED2 EIF4G2 KCNN2 PUM1 CAPRIN1 | 1.21e-04 | 734 | 118 | 12 | M3835 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | SOX2 ABCA2 DRD4 INAFM2 PCDHGC5 PCDHGB7 PCDHGB6 PRR36 PCDHGA11 PCDHGA10 ZBTB4 CCDC85C ZSWIM6 SAP30 TSC22D1 CDH24 PBX3 PCDHGC3 | 1.87e-05 | 1075 | 115 | 18 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-07 | 184 | 118 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 189 | 118 | 7 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 189 | 118 | 7 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 7.61e-07 | 190 | 118 | 7 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.61e-07 | 190 | 118 | 7 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.17e-07 | 192 | 118 | 7 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-07 | 193 | 118 | 7 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.70e-07 | 197 | 118 | 7 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-06 | 199 | 118 | 7 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.19e-06 | 142 | 118 | 6 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.47e-06 | 145 | 118 | 6 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.03e-06 | 164 | 118 | 6 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 168 | 118 | 6 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-06 | 172 | 118 | 6 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 176 | 118 | 6 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 176 | 118 | 6 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 180 | 118 | 6 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.72e-06 | 184 | 118 | 6 | 629cfed10e1112cf30f6a828ce9efbbc6b207789 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 1.00e-05 | 185 | 118 | 6 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 186 | 118 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-05 | 186 | 118 | 6 | 10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.17e-05 | 190 | 118 | 6 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.24e-05 | 192 | 118 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.27e-05 | 193 | 118 | 6 | 32d139f922cd19adc1cc1e0e9a828115be9945d6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 193 | 118 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.27e-05 | 193 | 118 | 6 | 91955c3773c9729a96e82f240f06b072367970d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 193 | 118 | 6 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-05 | 194 | 118 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-05 | 194 | 118 | 6 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | severe-B_intermediate|World / disease stage, cell group and cell class | 1.35e-05 | 195 | 118 | 6 | ce4bd004ceb05a269387adfed255d7fa393afcc6 | |
| ToppCell | mild_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 1.35e-05 | 195 | 118 | 6 | 74f0f709d9b3eed5d7e02a51884f02cc281782f1 | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 1.39e-05 | 196 | 118 | 6 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.43e-05 | 197 | 118 | 6 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 197 | 118 | 6 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.43e-05 | 197 | 118 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.47e-05 | 198 | 118 | 6 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 198 | 118 | 6 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | Basal-basal-10|World / Class top | 1.52e-05 | 199 | 118 | 6 | 4fadfc58102b21bf9db9d0092f3437aa78fddd99 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive|COVID-19_Severe / Disease, condition lineage and cell class | 1.56e-05 | 200 | 118 | 6 | 5ba9c541fa356d34f392a63274dcd7bfb844cbb6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.56e-05 | 200 | 118 | 6 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 118 | 6 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 118 | 6 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.56e-05 | 200 | 118 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 118 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | mild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-05 | 200 | 118 | 6 | d0467cab6a42bf780aa49046bf3231ca161dc144 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 124 | 118 | 5 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.10e-05 | 144 | 118 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.67e-05 | 148 | 118 | 5 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.82e-05 | 149 | 118 | 5 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.82e-05 | 155 | 118 | 5 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.76e-05 | 160 | 118 | 5 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.76e-05 | 160 | 118 | 5 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-05 | 165 | 118 | 5 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.05e-05 | 166 | 118 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-pDC|Liver / Manually curated celltypes from each tissue | 8.05e-05 | 166 | 118 | 5 | 24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.28e-05 | 167 | 118 | 5 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 167 | 118 | 5 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 167 | 118 | 5 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.28e-05 | 167 | 118 | 5 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Pvalb_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.46e-05 | 87 | 118 | 4 | fd0df79b02f96463a6bad90dcd019c59c8e3eb0e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-05 | 168 | 118 | 5 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.75e-05 | 169 | 118 | 5 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.25e-05 | 171 | 118 | 5 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.25e-05 | 171 | 118 | 5 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.25e-05 | 171 | 118 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.25e-05 | 171 | 118 | 5 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 172 | 118 | 5 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.51e-05 | 172 | 118 | 5 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 172 | 118 | 5 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.51e-05 | 172 | 118 | 5 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.77e-05 | 173 | 118 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.77e-05 | 173 | 118 | 5 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | Severe-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.00e-04 | 174 | 118 | 5 | f3f8c924420f46321bd47e2b97f18c7241541599 | |
| ToppCell | Basal-basal-3|World / Class top | 1.03e-04 | 175 | 118 | 5 | a0d7ced5204a9efbbb91ac99410a088f8ed2df0f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 118 | 5 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 118 | 5 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 176 | 118 | 5 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 1.06e-04 | 176 | 118 | 5 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 176 | 118 | 5 | 045b12c90f7dd49a9778dadcdf8f18125b380531 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-04 | 177 | 118 | 5 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 177 | 118 | 5 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 178 | 118 | 5 | be4976bbfd9ebbc568155ede99a07670c43aa372 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 178 | 118 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 178 | 118 | 5 | 91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 179 | 118 | 5 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 179 | 118 | 5 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 179 | 118 | 5 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 180 | 118 | 5 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 181 | 118 | 5 | 6df40f86c569b6ecfc3137a68d1355b012dbf6bf | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 181 | 118 | 5 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 182 | 118 | 5 | 862cc68006918e9e46e22b236302d862737f1061 | |
| Drug | CID9959010 | 4.84e-08 | 39 | 118 | 6 | CID009959010 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 5.07e-07 | 184 | 118 | 9 | 5671_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.57e-07 | 193 | 118 | 9 | 4202_DN | |
| Drug | montmorillonite | 1.95e-06 | 40 | 118 | 5 | CID000517273 | |
| Drug | lactofen | 4.03e-06 | 81 | 118 | 6 | CID000062276 | |
| Drug | valproate | DRD4 PCDHGC5 PCDHGB7 PCDHGA11 PCDHGA10 SAP30 GSK3A RYR1 JUN SLC2A13 PCDHGC3 | 4.82e-06 | 381 | 118 | 11 | CID000003121 |
| Drug | AC1L1UVI | 9.71e-06 | 55 | 118 | 5 | CID000061263 | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.87e-06 | 200 | 118 | 8 | 7182_DN | |
| Drug | IBI-C83 | 1.11e-05 | 9 | 118 | 3 | CID000068764 | |
| Drug | 2-oxothiazolidine-4-carboxylic acid | 1.11e-05 | 9 | 118 | 3 | ctd:C029536 | |
| Drug | iododimethylarsine | 1.11e-05 | 9 | 118 | 3 | CID000069608 | |
| Drug | methylarsine oxide | 1.11e-05 | 9 | 118 | 3 | ctd:C080197 | |
| Drug | 5-amino-2-nitrobenzoic acid | 1.11e-05 | 9 | 118 | 3 | CID000083298 | |
| Drug | A25618 | SOX2 PCDHGC5 PCDHGB7 PCDHGA11 PCDHGA10 PPP1R14C ESRRB GATA4 YY1 MEF2C SAP30 JUN TSC22D1 SAFB PCDHGC3 | 1.20e-05 | 777 | 118 | 15 | CID000005562 |
| Drug | AC1L1B7B | 1.47e-05 | 29 | 118 | 4 | CID000001314 | |
| Drug | BOCPheONP | 2.66e-05 | 2 | 118 | 2 | CID000111308 | |
| Drug | MPM-06 | 2.66e-05 | 2 | 118 | 2 | CID000161546 | |
| Drug | NSC-374899 | 2.66e-05 | 2 | 118 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 2.66e-05 | 2 | 118 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 2.66e-05 | 2 | 118 | 2 | CID004418081 | |
| Drug | c189 | 2.66e-05 | 2 | 118 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 2.66e-05 | 2 | 118 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 2.66e-05 | 2 | 118 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 2.66e-05 | 2 | 118 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 2.66e-05 | 2 | 118 | 2 | CID000074924 | |
| Drug | p-toluamidine | 2.66e-05 | 2 | 118 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 2.66e-05 | 2 | 118 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 2.66e-05 | 2 | 118 | 2 | CID000011607 | |
| Drug | Sp 1 (pharmaceutical) | TCF4 PCDHGC5 PCDHGB7 MNX1 PCDHGA11 PCDHGA10 YY1 SAP30 JUN JUND PURA PCDHGC3 | 2.82e-05 | 548 | 118 | 12 | CID000099040 |
| Drug | 17-isoprogesterone | ABCA2 PCDHGC5 PCDHGB7 PCDHGA11 PCDHGA10 ESRRB GATA4 IRS1 ADCY5 GSK3A NEFH JUN JUND SAFB CDK13 SLC2A13 PCDHGC3 MAF | 3.27e-05 | 1170 | 118 | 18 | CID000004920 |
| Drug | AC1O5LBK | 3.88e-05 | 242 | 118 | 8 | CID006436256 | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 4.03e-05 | 178 | 118 | 7 | 579_DN | |
| Drug | methyloxoarsine | 4.74e-05 | 14 | 118 | 3 | CID000092815 | |
| Drug | Dextroamphetamine | 5.15e-05 | 185 | 118 | 7 | ctd:D003913 | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 1856_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 7322_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 5952_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 2243_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 7300_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 7.90e-05 | 198 | 118 | 7 | 5444_DN | |
| Drug | N-acetylbenzotriazole | 7.96e-05 | 3 | 118 | 2 | CID000087784 | |
| Drug | photophor | 7.96e-05 | 3 | 118 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 7.96e-05 | 3 | 118 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 7.96e-05 | 3 | 118 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 7.96e-05 | 3 | 118 | 2 | CID000171547 | |
| Drug | AFMeq | 7.96e-05 | 3 | 118 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 7.96e-05 | 3 | 118 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 7.96e-05 | 3 | 118 | 2 | CID000188995 | |
| Drug | AC1L49DM | 7.96e-05 | 3 | 118 | 2 | CID000152933 | |
| Drug | c140 | 7.96e-05 | 3 | 118 | 2 | CID002783250 | |
| Drug | Benzamidomethaneboronic acid | 7.96e-05 | 3 | 118 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 7.96e-05 | 3 | 118 | 2 | CID000076323 | |
| Drug | FK-386 | 7.96e-05 | 3 | 118 | 2 | CID000135044 | |
| Drug | FK-375 | 7.96e-05 | 3 | 118 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 7.96e-05 | 3 | 118 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 7.96e-05 | 3 | 118 | 2 | CID000328214 | |
| Drug | C18 4 | 7.96e-05 | 3 | 118 | 2 | CID000077248 | |
| Drug | taraxastane | 7.96e-05 | 3 | 118 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 7.96e-05 | 3 | 118 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 7.96e-05 | 3 | 118 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 7.96e-05 | 3 | 118 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 7.96e-05 | 3 | 118 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 7.96e-05 | 3 | 118 | 2 | CID000070396 | |
| Drug | Z-Phe-OMe | 7.96e-05 | 3 | 118 | 2 | CID003082435 | |
| Drug | 3-methylcoumarin | 7.96e-05 | 3 | 118 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 7.96e-05 | 3 | 118 | 2 | CID000102124 | |
| Drug | FK-316 | 7.96e-05 | 3 | 118 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 7.96e-05 | 3 | 118 | 2 | CID000000694 | |
| Drug | Marinostatin D | 7.96e-05 | 3 | 118 | 2 | CID000132206 | |
| Drug | 1FD7 | 7.96e-05 | 3 | 118 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 7.96e-05 | 3 | 118 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 7.96e-05 | 3 | 118 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 7.96e-05 | 3 | 118 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 7.96e-05 | 3 | 118 | 2 | CID000193527 | |
| Drug | FK-448 | 7.96e-05 | 3 | 118 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 7.96e-05 | 3 | 118 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 7.96e-05 | 3 | 118 | 2 | CID000133906 | |
| Drug | arsenite | 8.33e-05 | 347 | 118 | 9 | CID000000544 | |
| Drug | kazinol B | 8.75e-05 | 17 | 118 | 3 | CID000480869 | |
| Drug | AC1Q7A7H | 1.03e-04 | 47 | 118 | 4 | CID000112184 | |
| Drug | pilocarpine- | 1.19e-04 | 147 | 118 | 6 | CID000004819 | |
| Drug | AC1L3XQA | 1.24e-04 | 19 | 118 | 3 | CID000124009 | |
| Drug | SK&F 82958 | 1.24e-04 | 19 | 118 | 3 | ctd:C071262 | |
| Drug | DB04618 | 1.42e-04 | 51 | 118 | 4 | CID004369393 | |
| Drug | Isoflavones | 1.44e-04 | 218 | 118 | 7 | ctd:D007529 | |
| Drug | AC1L3X0P | 1.45e-04 | 20 | 118 | 3 | CID000123636 | |
| Drug | Dt-f | 1.45e-04 | 20 | 118 | 3 | CID000657098 | |
| Drug | Benzoyl-dl-leucine | 1.59e-04 | 4 | 118 | 2 | CID000294887 | |
| Drug | Acafcek | 1.59e-04 | 4 | 118 | 2 | CID000197677 | |
| Drug | B-1,3-od | 1.59e-04 | 4 | 118 | 2 | CID011971053 | |
| Drug | chromium (D-Phenylalanine)3 | 1.59e-04 | 4 | 118 | 2 | ctd:C512471 | |
| Drug | dehydromerodesmosine | 1.59e-04 | 4 | 118 | 2 | CID006443540 | |
| Drug | alpha-amyrin palmitate | 1.59e-04 | 4 | 118 | 2 | CID000185477 | |
| Drug | poly-THIQ | 1.59e-04 | 4 | 118 | 2 | CID006453487 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 1.59e-04 | 4 | 118 | 2 | CID011548799 | |
| Drug | G2505_sigma | 1.59e-04 | 4 | 118 | 2 | CID000111098 | |
| Drug | p-fluorobenzenesulfonyl chloride | 1.59e-04 | 4 | 118 | 2 | CID000009588 | |
| Drug | BSSDA | 1.59e-04 | 4 | 118 | 2 | CID003081106 | |
| Drug | NSC717830 | 1.59e-04 | 4 | 118 | 2 | CID005472313 | |
| Drug | AC1L2HV6 | 1.59e-04 | 4 | 118 | 2 | CID000047328 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 PCDHGC3 | 2.24e-13 | 71 | 116 | 10 | EFO_0007878, EFO_0007979 |
| Disease | mental development measurement | 5.40e-10 | 25 | 116 | 6 | EFO_0008230 | |
| Disease | lymphocyte count | FNIP2 TCF4 PDE4D PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 TNRC6B GSX2 ADCY5 NFE2L3 TAF8 CDK13 GATAD1 RERE PCDHGC3 | 2.46e-07 | 1464 | 116 | 21 | EFO_0004587 |
| Disease | renal carcinoma (biomarker_via_orthology) | 5.89e-07 | 5 | 116 | 3 | DOID:4451 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.87e-06 | 93 | 116 | 6 | C1535926 | |
| Disease | Sarcosine measurement | 1.90e-06 | 23 | 116 | 4 | EFO_0021668 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 1.35e-05 | 37 | 116 | 4 | DOID:0050865 (is_marker_for) | |
| Disease | level of chymotrypsinogen B2 in blood serum | 1.53e-05 | 2 | 116 | 2 | OBA_2041192 | |
| Disease | chymotrypsinogen B measurement | 4.58e-05 | 3 | 116 | 2 | EFO_0801477 | |
| Disease | mean platelet volume | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA5 PCDHGA1 GATA4 IRS1 MEF2C ZBTB10 PCDHGC3 | 4.87e-05 | 1020 | 116 | 14 | EFO_0004584 |
| Disease | Grand Mal Status Epilepticus | 1.44e-04 | 67 | 116 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.44e-04 | 67 | 116 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.44e-04 | 67 | 116 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.44e-04 | 67 | 116 | 4 | C0751523 | |
| Disease | Petit mal status | 1.44e-04 | 67 | 116 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.44e-04 | 67 | 116 | 4 | C0393734 | |
| Disease | Status Epilepticus | 1.52e-04 | 68 | 116 | 4 | C0038220 | |
| Disease | congestive heart failure (is_implicated_in) | 1.62e-04 | 27 | 116 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | intellectual disability (is_implicated_in) | 2.22e-04 | 30 | 116 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | Abnormal corpus callosum morphology | 2.27e-04 | 6 | 116 | 2 | C1842581 | |
| Disease | Septo-Optic Dysplasia | 3.18e-04 | 7 | 116 | 2 | C0338503 | |
| Disease | Abnormality of refraction | 3.32e-04 | 673 | 116 | 10 | HP_0000539 | |
| Disease | Hodgkin's lymphoma (is_marker_for) | 4.22e-04 | 8 | 116 | 2 | DOID:8567 (is_marker_for) | |
| Disease | granule cell layer dentate gyrus volume | 4.22e-04 | 8 | 116 | 2 | EFO_0009403 | |
| Disease | Abnormality of the face | 5.42e-04 | 9 | 116 | 2 | C4025871 | |
| Disease | trypsin-2 measurement | 8.23e-04 | 11 | 116 | 2 | EFO_0008305 | |
| Disease | schizophrenia, anorexia nervosa | 9.00e-04 | 48 | 116 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 9.00e-04 | 48 | 116 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 9.00e-04 | 48 | 116 | 3 | C1862941 | |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 9.86e-04 | 12 | 116 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.01e-03 | 50 | 116 | 3 | C1862939 | |
| Disease | sitting height ratio | 1.07e-03 | 51 | 116 | 3 | EFO_0007118 | |
| Disease | pain | 1.09e-03 | 196 | 116 | 5 | EFO_0003843 | |
| Disease | Peripheral Nervous System Diseases | 1.27e-03 | 54 | 116 | 3 | C4721453 | |
| Disease | Opioid use measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0009937 | |
| Disease | lateral ventricle volume change measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0021502 | |
| Disease | obesity (implicated_via_orthology) | 1.63e-03 | 215 | 116 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.98e-03 | 447 | 116 | 7 | C3714756 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.98e-03 | 63 | 116 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Neoplastic Cell Transformation | 2.25e-03 | 139 | 116 | 4 | C0007621 | |
| Disease | Alzheimer disease, polygenic risk score | 2.25e-03 | 586 | 116 | 8 | EFO_0030082, MONDO_0004975 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 2.25e-03 | 18 | 116 | 2 | EFO_1000649, HP_0000131 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.26e-03 | 66 | 116 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Animal Mammary Neoplasms | 2.43e-03 | 142 | 116 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 2.43e-03 | 142 | 116 | 4 | C1257925 | |
| Disease | Alzheimer disease, educational attainment | 2.98e-03 | 247 | 116 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | Sarcoma | 3.06e-03 | 21 | 116 | 2 | C1261473 | |
| Disease | Amphetamine-Related Disorders | 3.25e-03 | 75 | 116 | 3 | C0236733 | |
| Disease | Amphetamine Abuse | 3.25e-03 | 75 | 116 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 3.25e-03 | 75 | 116 | 3 | C0236804 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.25e-03 | 75 | 116 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | PCDHGA5 PCDHGA1 CTRB2 CCDC85C GSX2 YY1 ASTN2 SUZ12 PJA1 CTRB1 PBX2 MN1 | 3.29e-03 | 1228 | 116 | 12 | EFO_0004713 |
| Disease | Mammary Neoplasms, Experimental | 3.33e-03 | 155 | 116 | 4 | C0024668 | |
| Disease | unipolar depression, bipolar disorder | 3.40e-03 | 156 | 116 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | atrial fibrillation | 3.53e-03 | 371 | 116 | 6 | EFO_0000275 | |
| Disease | JT interval, response to sulfonylurea | 3.67e-03 | 23 | 116 | 2 | EFO_0007885, EFO_0007922 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGASGVSSCMGDSGG | 201 | Q6GPI1 | |
| AAAAATNGTGGSSGM | 6 | Q7L5N1 | |
| SGAGERGSGGVANAS | 21 | P18825 | |
| RFGSGAAGGSGSSSS | 56 | Q3ZCQ3 | |
| GAAAAAGTGGTGSDS | 141 | Q6ZU67 | |
| AAATAAAAGGGGSTA | 236 | Q99490 | |
| AAAGGGGSTASTSGG | 241 | Q99490 | |
| GGSTASTSGGVGAGA | 246 | Q99490 | |
| GGGGAASLSKAAAGS | 466 | Q8NFD5 | |
| GGGSAAAAASAGGTE | 136 | O95622 | |
| SGSSGSEAAAGAGAA | 21 | Q14444 | |
| NRAASAAGAAGSAGG | 26 | Q9UKY7 | |
| AAGAAGSAGGSSGAA | 31 | Q9UKY7 | |
| GGTASAGAAGPGAAT | 61 | Q9UKY7 | |
| GASAATAATAAGGTG | 161 | Q14004 | |
| TAATAAGGTGGSGGS | 166 | Q14004 | |
| GAGTGAGAAAAAASP | 91 | O75129 | |
| GGGGESRSSGAASSA | 146 | Q96T37 | |
| LTGGGTAAGVAGAAA | 86 | P20936 | |
| VGGGGSARAQAAGSS | 66 | Q8TE59 | |
| SEAADGSSTLGGGAG | 856 | Q9Y5G8 | |
| EAADGSSTLGGGAGT | 861 | Q9Y5H2 | |
| EAADGSSTLGGGAGT | 856 | Q9Y5F9 | |
| AADGSSTLGGGAGTM | 856 | Q9Y5F8 | |
| GAATESGGAAGFATG | 726 | P32926 | |
| SGGAAGFATGTVSGA | 731 | P32926 | |
| GFATGTVSGAASGFG | 736 | P32926 | |
| GGGSAAAAAAAAASG | 126 | P40426 | |
| AGSGGSFNLSGSGDM | 341 | P40425 | |
| AAGAGAGASLGGSGE | 141 | O75444 | |
| GAAGSAAASAGGAGG | 201 | O75444 | |
| GLGGAGASTSGSSGA | 586 | Q9UNF1 | |
| SGGAAAAGSGGSRAG | 31 | A5PLN7 | |
| AVASVAGGSGSGGFS | 146 | P05412 | |
| AGGSGSGGFSASLHS | 151 | P05412 | |
| GGGGGASSPSAAAAA | 41 | Q9H2S1 | |
| AGAAAGAATGTVAGA | 281 | Q8IYT1 | |
| VTSLAAAASGTGGGG | 31 | P50219 | |
| GSGAAGSSQTGDALG | 311 | P15884 | |
| LSVGGSGFSASSGRG | 546 | P13647 | |
| GSGGGGAVAAASGAA | 26 | Q8N3F9 | |
| AAAAAAGGPSGTATG | 161 | P17535 | |
| AALAATGAASGGGGG | 156 | A6NKD9 | |
| GSLSSLGSGSEAGGA | 776 | Q86UP0 | |
| SSRGSVGAGSGGAGA | 71 | Q9BZM3 | |
| TGASGMAGTTGGVDA | 1726 | Q7Z5P9 | |
| AGSTGTSGQSAGVAG | 3451 | Q7Z5P9 | |
| SEAADGSSTLGGGAG | 861 | Q9Y5H3 | |
| SEAADGSSTLGGGAG | 856 | Q9Y5G2 | |
| AADGSSTLGGGAGTM | 871 | Q9Y5F6 | |
| RAGSGEGSDSAGGAT | 11 | Q08499 | |
| GLLGAAAASSTGGAG | 126 | Q9Y4A8 | |
| AAASSTGGAGASVDG | 131 | Q9Y4A8 | |
| TGGAGASVDGGSQAV | 136 | Q9Y4A8 | |
| IGSGFSSAFGGSSSG | 41 | Q7Z3Z0 | |
| GGGAEARGATAGASA | 46 | Q6ZV70 | |
| AVASAASAGNVTGGG | 31 | Q9H1U4 | |
| GGDLTSGAGTSAGNG | 201 | Q06413 | |
| GSLSGQADGSSGGAT | 21 | Q8IVH2 | |
| ASSAAGVSGPSSAGG | 11 | Q9NX70 | |
| AADGSSTLGGGAGTM | 856 | Q9Y5G1 | |
| AADGSSTLGGGAGTM | 861 | Q9UN70 | |
| AGAAVGGGGGSSSSS | 1121 | P35568 | |
| AEGGASRFSASSGGG | 6 | P78344 | |
| MSSLGGGSQDAGGSS | 1 | Q7LFL8 | |
| SSGLVGTSMGAGSGA | 976 | Q02413 | |
| GASAGASAGLAGQGA | 21 | P21917 | |
| AAASANGAAGGLAGT | 601 | Q14671 | |
| KGGAGGTRSAAGSSS | 31 | P12036 | |
| SASGGASGGSSGGAA | 61 | P43694 | |
| ASVGAMGGGVGASSS | 51 | P49840 | |
| GLSEACGGAGSSGSA | 171 | Q96GS4 | |
| GGGGFGAATFASTSA | 56 | Q8WUU5 | |
| AADLGTASHGAGGTG | 816 | Q9P278 | |
| MSSGADGGGGAAVAA | 1 | Q5JPI9 | |
| GAVGGGGTSQASAGA | 11 | Q96IK1 | |
| GGTSQASAGAATGAT | 16 | Q96IK1 | |
| ASAGAATGATGASGG | 21 | Q96IK1 | |
| HGGTATDTGRAGSGA | 221 | Q86X59 | |
| GAEGGGSSSGNVSGV | 116 | Q96RY5 | |
| TSGAAAAGGTRAGSE | 16 | Q16829 | |
| AGAGSSGGSSGVSGD | 66 | P85037 | |
| SGGSSGVSGDSAVAG | 71 | P85037 | |
| SGAGGAANGTGAGAV | 361 | Q9BZC7 | |
| AGGGGSGAAAATAAT | 16 | O00458 | |
| MAASGESGTSGGGGS | 1 | O75937 | |
| SGSSDASGGFGLALG | 36 | O95718 | |
| MAAGGGGGSSKASSS | 1 | Q5VT52 | |
| SAAGDVSGAGSGGSS | 4596 | P21817 | |
| AGASGVSSCMGDSGG | 201 | P17538 | |
| GALVGAASGSSAGGS | 36 | Q9Y5R6 | |
| SRGGGSGSGASDLGA | 51 | Q9Y5R6 | |
| AGAEAVSGGGSGTGA | 481 | Q8IU81 | |
| NATGPSGTSGAAAAG | 81 | P0DMQ5 | |
| GSSETAGGASGGGAR | 6 | Q8TAE6 | |
| GSGGAGSGSAAGLLA | 271 | O60422 | |
| SEAADGSSTLGGGAG | 856 | Q9Y5H4 | |
| ASGAAVGGSSAGETR | 981 | Q10571 | |
| ESSTSLQSAGAGGGG | 46 | Q96QE2 | |
| GGGGNVAASSSTGGD | 46 | Q15542 | |
| MADAAATAGAGGSGT | 1 | Q7Z7C8 | |
| QTSGGGGGNSTAAAA | 16 | P48431 | |
| ANAAGGANSGGGSSG | 111 | P41225 | |
| AAAAASAGNGTGAGT | 26 | O75446 | |
| SSGGSASAGAGLWAA | 31 | Q5TCX8 | |
| TSGGKAAAGAGAGAS | 1221 | Q9H6K5 | |
| SGAAASGGSIAGGSS | 1071 | Q9P2R6 | |
| RGSGSGSASALNAAG | 31 | Q15714 | |
| GSASALNAAGTGVGS | 36 | Q15714 | |
| GTAVGATGSGIAAAA | 11 | Q92922 | |
| AAGSQEAGTGAGAGS | 31 | Q8NBK3 | |
| EAGTGAGAGSLAGSC | 36 | Q8NBK3 | |
| SGLGDSGAAGAAALS | 6 | Q15424 | |
| TLSSLSAEGGGSAGG | 1696 | Q9Y566 | |
| SDGGRGGLGATASAT | 5066 | Q8IVF2 | |
| GGLGATASATGSEGV | 5071 | Q8IVF2 | |
| AAGGGSSGQVTSNGS | 16 | O96005 | |
| AEGSGGGGSLSASSR | 31 | Q5T1Q4 | |
| QGTAAGSTGGSSEGL | 2126 | Q9C0A1 | |
| STSAGFGSGAASLGA | 1411 | Q12816 | |
| VAAATASGGKSGGGS | 31 | Q15022 | |
| LGSTGGSSGTNGSNA | 491 | Q9UMX0 | |
| VTVAAAGKSGGGGSS | 151 | P25490 | |
| GGGSGTASTGGSQAA | 491 | Q9P1Z0 | |
| EGRGSASSGGAAAGA | 981 | Q96JE7 | |
| GGGGSSSSPAATSAA | 151 | Q9HCJ5 | |
| ASLGDGSGAEGGSCS | 191 | Q96DT7 | |
| GAAGFSSSGPAATSG | 71 | P48556 | |
| ASGAGVGSGGASSDA | 26 | Q96K80 | |
| ASASAGAGAGASAGS | 421 | Q8NG27 | |
| SGSEQGGAALGSGGS | 6 | Q00577 | |
| LQSGSAASGGSGAGG | 791 | Q9ULM3 | |
| SSSAGGSSGADLAGA | 1776 | Q9UPQ9 | |
| GLGVQGAASAGASGT | 781 | Q5EBL2 | |
| GGQLGSSAAEGSGSG | 286 | Q8NCA9 | |
| AATAAVEGSGGSGGG | 46 | P22459 | |
| ASASSGGAGAAVGTG | 191 | P17275 |